Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02597790 · ClinicalTrials.gov registry record
A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 87
- Enrollment target
NCT02597790 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 87 participants.
The verdict
NCT02597790 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The CTSI-PLACE Study is a study for men and women with HIV/hepatitis C co-infection or HIV only. The study looks at the impact of having hepatitis C virus in addition to HIV on risk for cardiovascular disease. Participants will undergo non-invasive assessment of cardiovascular disease risk through measurements of endothelial function and blood biomarkers at baseline and 1 year (or 4 weeks and 24 weeks after end of HCV treatment for those that undergo HCV treatment during study follow-up).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2013-10 |
| Est. Completion | 2020-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02597790
The ClinicalTrials.gov registry entry for NCT02597790 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02597790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02597790 about?
NCT02597790 is a clinical study titled "A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects". The CTSI-PLACE Study is a study for men and women with HIV/hepatitis C co-infection or HIV only. The study looks at the impact of having hepatitis C virus in addition to HIV on risk for cardiovascular disease. Participants will undergo non-invasive assessment of cardiovascular disease risk through m...
What is the current status of trial NCT02597790?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2013-10. Estimated completion is 2020-01.
Who is sponsoring clinical trial NCT02597790?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.